5,401
Views
18
CrossRef citations to date
0
Altmetric
Coronaviruses

Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein

ORCID Icon, , , ORCID Icon, , , , , , , , , , , , , , , , , , & ORCID Icon show all
Pages 351-367 | Received 04 Nov 2021, Accepted 28 Dec 2021, Published online: 24 Jan 2022

References

  • Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
  • Zhu N, Zhang DY, Wang WL, et al. A novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020 Feb 20;382(8):727–733. doi: 10.1056/NEJMoa2001017
  • Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71–76. doi: 10.1016/j.ijsu.2020.02.034
  • Gorbalenya AE, Baker SC, Baric RS, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020 Apr;5(4):536–544. doi: 10.1038/s41564-020-0695-z
  • Yan RH, Zhang YY, Li YN, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 27;367(6485):1444. doi: 10.1126/science.abb2762
  • Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020 May 14;181(4):894–904 e9. doi: 10.1016/j.cell.2020.03.045
  • Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020 May;581(7807):215–220. doi: 10.1038/s41586-020-2180-5
  • Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020 May;581(7807):221–224. doi: 10.1038/s41586-020-2179-y
  • Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr 16;181(2):281–292e6. doi: 10.1016/j.cell.2020.02.058
  • Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar 13;367(6483):1260–1263. doi: 10.1126/science.abb2507
  • Xu C, Wang Y, Liu C, et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci Adv. 2021 Jan;7(1):eabe5575. doi: 10.1126/sciadv.abe5575
  • Cai Y, Zhang J, Xiao T, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020 Sep 25;369(6511):1586–1592. doi: 10.1126/science.abd4251
  • Xiong X, Qu K, Ciazynska KA, et al. A thermostable, closed, SARS-CoV-2 spike protein trimer. bioRxiv.
  • Wrobel AG, Benton DJ, Xu P, et al. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol. 2020 Aug;27(8):763–767. doi: 10.1038/s41594-020-0468-7
  • Corti D, Purcell LA, Snell G, et al. Tackling COVID-19 with neutralizing monoclonal antibodies. Cell. 2021 Jun 10;184(12):3086–3108. doi: 10.1016/j.cell.2021.05.005
  • Barnes CO, Jette CA, Abernathy ME, et al. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature. 2020 Dec;588(7839):682–687. doi: 10.1038/s41586-020-2852-1
  • Chi X, Yan R, Zhang J, et al. A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2. Science. 2020 Aug 7;369(6504):650–655. doi: 10.1126/science.abc6952
  • Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 Aug;584(7821):450–456. doi: 10.1038/s41586-020-2571-7
  • McCallum M, De Marco A, Lempp FA, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 Apr 29;184(9):2332–2347e16. doi: 10.1016/j.cell.2021.03.028
  • Harvey WT, Carabelli AM, Jackson B, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jul;19(7):409–424. doi: 10.1038/s41579-021-00573-0
  • Dejnirattisai W, Zhou D, Ginn HM, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021 Apr 15;184(8):2183–2200e22. doi: 10.1016/j.cell.2021.02.032
  • Greaney AJ, Starr TN, Gilchuk P, et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe. 2021 Jan 13;29(1):44–57e9. doi: 10.1016/j.chom.2020.11.007
  • Cerutti G, Guo Y, Zhou T, et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021 May 12;29(5):819–833e7. doi: 10.1016/j.chom.2021.03.005
  • Li D, Edwards RJ, Manne K, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 Aug 5;184(16):4203–4219 e32. doi: 10.1016/j.cell.2021.06.021
  • Jennewein MF, MacCamy AJ, Akins NR, et al. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 Jul 13;36(2):109353. doi: 10.1016/j.celrep.2021.109353
  • Huang Y, Nguyen AW, Hsieh C-L, et al. Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses. bioRxiv. 2021.
  • Singh J, Rahman SA, Ehtesham NZ, et al. SARS-CoV-2 variants of concern are emerging in India. Nat Med. 2021 Jul;27(7):1131–1133. doi: 10.1038/s41591-021-01397-4
  • Martinez DR, Schafer A, Leist SR, et al. Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice. Cell Rep. 2021 Jul 27;36(4):109450. doi: 10.1016/j.celrep.2021.109450
  • Chen RE, Zhang X, Case JB, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 Apr;27(4):717–726. doi: 10.1038/s41591-021-01294-w
  • Wang L, Zhou T, Zhang Y, et al. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants. bioRxiv.
  • Wang P, Nair MS, Liu L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 May;593(7857):130–135. doi: 10.1038/s41586-021-03398-2
  • Li Q, Nie J, Wu J, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021 Apr 29;184(9):2362–2371e9. doi: 10.1016/j.cell.2021.02.042
  • Supasa P, Zhou D, Dejnirattisai W, et al. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 Apr 15;184(8):2201–2211e7. doi: 10.1016/j.cell.2021.02.033
  • Williams SV, Vusirikala A, Ladhani SN, et al. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. Euro Surveill. 2021 Jul;26(27). https://doi.org/10.2807/1560-7917.ES.2021.26.27.2100626
  • Iacobucci G. Covid-19: Local councils initiate surge vaccination to tackle B.1.617.2 variant. Br Med J. 2021 May 25;373:n1361. doi: 10.1136/bmj.n1361
  • Dougherty K, Mannell M, Naqvi O, et al. SARS-CoV-2 B.1.617.2 (delta) variant COVID-19 outbreak associated with a gymnastics facility – Oklahoma, April–May 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):1004–1007. doi: 10.15585/mmwr.mm7028e2
  • Zhang C, Wang Y, Zhu Y, et al. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections. Nat Commun. 2021 Jan 11;12(1):264. doi: 10.1038/s41467-020-20465-w
  • Rong Z, Zhigang Y, Yuyan W, et al. Isolation of a 2019 novel coronavirus strain from a coronavirus disease 19 patient in Shanghai. Journal of Microbes and Infections. 2020;15(1):111–121.
  • Yang Y, Zang J, Xu S, et al. Elicitation of broadly neutralizing antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 variants by three prototype strain-derived recombinant protein vaccines. Viruses. 2021 Jul 22;13(8):1421. doi: 10.3390/v13081421
  • Qu P, Zhang C, Li M, et al. A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein. Cell Discov. 2020 2020/02/04;6(1):5. doi: 10.1038/s41421-019-0140-8
  • Zhang C, Xu C, Dai W, et al. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Nat Commun. 2021 May 18;12(1):2904. doi: 10.1038/s41467-021-23199-5
  • Ye J, Ma N, Madden TL, et al. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34–W40. doi: 10.1093/nar/gkt382
  • Yi Y, Wang S, Wang X, et al. Identification of human norovirus GII.3 blockade antibody epitopes. Viruses. 2021 Oct 13;13(10):2058. doi: 10.3390/v13102058
  • Giroglou T, Cinatl Jr J, Rabenau H, et al. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol. 2004 Sep;78(17):9007–9015. doi: 10.1128/JVI.78.17.9007-9015.2004
  • Dieterle ME, Haslwanter D, Bortz III RH, et al. A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition. Cell Host Microbe. 2020 Sep 9;28(3):486–496e6. doi: 10.1016/j.chom.2020.06.020
  • Zheng SQ, Palovcak E, Armache JP, et al. Motioncor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017 Apr;14(4):331–332. doi: 10.1038/nmeth.4193
  • Zivanov J, Nakane T, Forsberg BO, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018 Nov 9;7. https://doi.org/10.7554/eLife.42166
  • Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015 Nov;192(2):216–221. doi: 10.1016/j.jsb.2015.08.008
  • Punjani A, Rubinstein JL, Fleet DJ, et al. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017 Mar;14(3):290–296. doi: 10.1038/nmeth.4169
  • Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W252–W258. doi: 10.1093/nar/gku340
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta crystallographica section D. Biol Crystall. 2004 Dec;60(Pt 12 Pt 1):2126–2132. doi: 10.1107/S0907444904019158
  • Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004 Oct;25(13):1605–1612. doi: 10.1002/jcc.20084
  • DiMaio F, Song Y, Li X, et al. Atomic-accuracy models from 4.5-A cryo-electron microscopy data with density-guided iterative local refinement. Nat Methods. 2015 Apr;12(4):361–365. doi: 10.1038/nmeth.3286
  • Adams PD, Afonine PV, Bunkoczi G, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213–221. doi: 10.1107/S0907444909052925
  • Goddard TD, Huang CC, Meng EC, et al. UCSF chimerax: meeting modern challenges in visualization and analysis. Protein Sci. 2018 Jan;27(1):14–25. doi: 10.1002/pro.3235
  • Wang Y, Xu C, Wang Y, et al. Conformational dynamics of the Beta and Kappa SARS-CoV-2 spike proteins and their complexes with ACE2 receptor revealed by cryo-EM. Nat Commun. 2021 Dec 12;12(1):7345. doi: 10.1038/s41467-021-27350-0
  • Li D, Sempowski GD, Saunders KO, et al. SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment. Annu Rev Med. 2021 Aug 24. https://doi.org/10.1146/annurev-med-042420-113838
  • Hastie KM, Li H, Bedinger D, et al. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: a global consortium study. Science. 2021 Oct 22;374(6566):472–478. doi: 10.1126/science.abh2315
  • Tortorici MA, Beltramello M, Lempp FA, et al. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 Nov 20;370(6519):950–957. doi: 10.1126/science.abe3354
  • van Dorp L, Tan CC, Lam SD, et al. Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation. BioRxiv.
  • Interactive Real-Time Mutation Tracker. Available from: https://users.math.msu.edu/users/weig/SARS-CoV-2_Mutation_Tracker.html
  • Li D, Edwards RJ, Manne K, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021 Aug 5;184(16):4203–4219e32. doi: 10.1016/j.cell.2021.06.021
  • Huang Y, Nguyen AW, Hsieh C-L, et al. Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses. BioRxiv. 2021.
  • Pinto D, Sauer MM, Czudnochowski N, et al. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 Sep 3;373(6559):1109–1116. doi: 10.1126/science.abj3321